Open AccessTh17 Cells in Inflammatory Bowel Disease: An Update for the Clinician
Author(s) -
Guoqing Hou,
Shrinivas Bishu
Publication year - 2020
Publication title -
inflammatory bowel diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.932
H-Index - 146
eISSN - 1536-4844
pISSN - 1078-0998
DOI - 10.1093/ibd/izz316
Subject(s) - inflammatory bowel disease , pathogenesis , medicine , disease , inflammatory bowel diseases , immunology , crohn's disease , inflammation , bioinformatics , pathology , biology
Studies in humans strongly implicate Th17 cells in the pathogenesis of inflammatory bowel disease. Thus, Th17 cells are major targets of approved and emerging biologics. Herein, we review the role of Th17 in IBD with a clinical focus.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom